Pfizer’s mRNA Flu Vaccine Works Great, but RFK Jr. Might Ruin It for Everyone

Next-generation vaccines could make the flu season less of a snot-filled nightmare—if they ever reach the public, that is. Trial data out this week shows that Pfizer’s mRNA-based flu vaccine performed markedly better than a traditional shot.

On Wednesday, researchers published the results of a Phase III trial on the vaccine, funded by Pfizer, in the New England Journal of Medicine. The experimental vaccine was significantly more effective at preventing flu than a standard vaccine,…